abnormal response/metabolism to endogenous compounds_Foxn1<nu>/Foxn1<nu>,Gpc1<tm1.1Alan>/Gpc1<tm1.1Alan>

http://metadb.riken.jp/0003638ICD1Foxn1nuFoxn1nuGpc1tm11AlanGpc1tm11AlanFoxn1nuGpc1tm11Alan

abnormal response/metabolism to endogenous compounds_Foxn1<nu>/Foxn1<nu>,Gpc1<tm1.1Alan>/Gpc1<tm1.1Alan>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• glypican 1
  http://metadb.riken.jp/db/mgi_rdf/MGI:1194891
• forkhead box N1
  http://metadb.riken.jp/db/mgi_rdf/MGI:102949

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Foxn1<nu>/Foxn1<nu>,Gpc1<tm1.1Alan>/Gpc1<tm1.1Alan>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Foxn1<nu>|Gpc1<tm1.1Alan>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: CD-1

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• abnormal response/metabolism to endogenous compounds
  http://purl.obolibrary.org/obo/MP_0003638

文献

http://purl.org/net/cito/citesAsAuthority

• Takuma. Aikawa, et.al., Glypican-1 modulates the angiogenic and metastatic potential of human and mouse cancer cells., The Journal of clinical investigation, 2008, 118
  http://rdf.ncbi.nlm.nih.gov/pubmed/18064304